141 related articles for article (PubMed ID: 38215863)
1. Esketamine enhances memory reconsolidation in the novel object recognition task.
Li H; Ying L; Wan F; Shiqiao K; Yijie F; Chuli X; Xudong Y; Xinhong Y; Zhiyong X
Physiol Behav; 2024 Apr; 277():114461. PubMed ID: 38215863
[TBL] [Abstract][Full Text] [Related]
2. Urocanic acid enhances memory consolidation and reconsolidation in novel object recognition task.
Yu XD; Mo YX; He Z; Reilly J; Tian SW; Shu X
Biochem Biophys Res Commun; 2021 Nov; 579():62-68. PubMed ID: 34587556
[TBL] [Abstract][Full Text] [Related]
3. The role of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type receptor modulators in object recognition memory reconsolidation.
Man XY; Chang ZS; Mo YX; Liang K; Wang L; Xiao ZY
Neuroreport; 2022 Mar; 33(4):199-203. PubMed ID: 35143451
[TBL] [Abstract][Full Text] [Related]
4. Ketamine enhances novel object recognition memory reconsolidation via the BDNF/TrkB pathway in mice.
Fan JF; Tang ZH; Wang SY; Lei S; Zhang B; Tian SW
Physiol Behav; 2021 Dec; 242():113626. PubMed ID: 34673052
[TBL] [Abstract][Full Text] [Related]
5. Nicotine enhances the reconsolidation of novel object recognition memory in rats.
Tian S; Pan S; You Y
Pharmacol Biochem Behav; 2015 Feb; 129():14-8. PubMed ID: 25482325
[TBL] [Abstract][Full Text] [Related]
6. Esketamine for treatment resistant depression.
Swainson J; Thomas RK; Archer S; Chrenek C; MacKay MA; Baker G; Dursun S; Klassen LJ; Chokka P; Demas ML
Expert Rev Neurother; 2019 Oct; 19(10):899-911. PubMed ID: 31282772
[No Abstract] [Full Text] [Related]
7. Antipanic-like effect of esketamine and buprenorphine in rats exposed to acute hypoxia.
Maraschin JC; Frias AT; Hernandes PM; Batistela MF; Martinez LM; Joca SRL; Graeff FG; Audi EA; Spera de Andrade TGC; Zangrossi H
Behav Brain Res; 2022 Feb; 418():113651. PubMed ID: 34732354
[TBL] [Abstract][Full Text] [Related]
8. Esketamine: A Novel Option for Treatment-Resistant Depression.
Bozymski KM; Crouse EL; Titus-Lay EN; Ott CA; Nofziger JL; Kirkwood CK
Ann Pharmacother; 2020 Jun; 54(6):567-576. PubMed ID: 31795735
[No Abstract] [Full Text] [Related]
9. Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials.
Saad Z; Hibar D; Fedgchin M; Popova V; Furey ML; Singh JB; Kolb H; Drevets WC; Chen G
Int J Neuropsychopharmacol; 2020 Dec; 23(9):549-558. PubMed ID: 32367114
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacology of ketamine and esketamine as rapid-acting antidepressants].
Pavlidi P; Megalokonomou A; Sofron A; Kokras N; Dalla C
Psychiatriki; 2021 Dec; 32(Supplement I):55-63. PubMed ID: 34990380
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder.
Kryst J; Kawalec P; Pilc A
Expert Opin Pharmacother; 2020 Jan; 21(1):9-20. PubMed ID: 31663783
[No Abstract] [Full Text] [Related]
12. Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review.
Molero P; Ramos-Quiroga JA; Martin-Santos R; Calvo-Sánchez E; Gutiérrez-Rojas L; Meana JJ
CNS Drugs; 2018 May; 32(5):411-420. PubMed ID: 29736744
[TBL] [Abstract][Full Text] [Related]
13. Esketamine: Less Drowsiness, More Analgesia.
Mion G; Himmelseher S
Anesth Analg; 2024 Jul; 139(1):78-91. PubMed ID: 38295061
[TBL] [Abstract][Full Text] [Related]
14. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Hashimoto K
Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
[TBL] [Abstract][Full Text] [Related]
15. Role of glutamate receptors of central and basolateral amygdala nuclei on retrieval and reconsolidation of taste aversive memory.
Garcia-Delatorre P; Pérez-Sánchez C; Guzmán-Ramos K; Bermúdez-Rattoni F
Neurobiol Learn Mem; 2014 May; 111():35-40. PubMed ID: 24631645
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety of ketamine and esketamine in treatment of depression.
Nikayin S; Murphy E; Krystal JH; Wilkinson ST
Expert Opin Drug Saf; 2022 Jun; 21(6):777-787. PubMed ID: 35416105
[TBL] [Abstract][Full Text] [Related]
17. Retrieval is not necessary to trigger reconsolidation of object recognition memory in the perirhinal cortex.
Santoyo-Zedillo M; Rodriguez-Ortiz CJ; Chavez-Marchetta G; Bermudez-Rattoni F; Balderas I
Learn Mem; 2014 Sep; 21(9):452-6. PubMed ID: 25128536
[TBL] [Abstract][Full Text] [Related]
18. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
Koike H; Chaki S
Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
[TBL] [Abstract][Full Text] [Related]
19. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
[TBL] [Abstract][Full Text] [Related]
20. Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review.
Kumari S; Chaudhry HA; Sagot A; Doumas S; Abdullah H; Alcera E; Solhkhah R; Afzal S
Cureus; 2024 Feb; 16(2):e53987. PubMed ID: 38476783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
